We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on nickel and nickel compounds, including nickel carbonyl, nickel sulphate and nickel subsulphide, for responding to chemical incidents.
This proficiency testing (PT) scheme is suitable for laboratories that examine viruses in food products or waters using molecular methods.
An epidemiological study comparing the health of those exposed to nuclear weapons tests to a group of personnel not exposed to radiation.
Information on diisononyl phthalate (DINP) and di(2-ethylhexyl) phthalate (DEHP) for use in responding to chemical incidents.
Immediate actions in response to detection of vaccine derived polio virus type 2 (VDPV2) in London sewage samples.
Lists of those receiving pre-release access to UK Health Security Agency national norovirus and rotavirus surveillance reports
An overview of quality standards at the UK Health Security Agency's microbiology services based in Colindale.
How the UK Health Security Agency (UKHSA) applies the Code of Practice for Statistics in publication of the R value and growth rate estimates.
Flyer and poster on protection against German measles.
Assay intended for use by professionals and trained operators on the SAMBA II instrument system in clinical and point-of-care settings.
Information and procedural guidance on SSBBV testing.
Template letter to clinicians caring for patients who are immunosuppressed or are about to be immunosuppressed.
Reminds healthcare workers about measles presentation in young people, and to isolate them from immunosuppressed patients and pregnant women.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Privacy notices for participants in the Vivaldi study.
Information on white spirit for use in responding to chemical incidents.
Notifications of COVID-19 and influenza point-of-care testing (POCT) results: legal duties for providers of POCT.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).